The North America Digital Therapeutics Market would witness market growth of 20.9% CAGR during the forecast period (2021-2027). Digital Therapeutics is used through various digital platforms such as internet-based health technologies to supervise all the changes that occur in patient conditions. Mainly, digital treatment aims to monitor the alteration that occurs in the behaviour, lifestyle, and psychological condition of a patient.
These digital methods assist in real-time observation or collection of data to make a progress report or to take necessary prevention methods on the basis of digital stimulus. Digital therapeutics help in monitoring various health conditions like insomnia, obesity, depression, anxiety, chronic diseases, dementia, etc. The digital therapeutics market is witnessing more investments from investors owing to the increasing consumer interest in digital therapeutics platforms.
Favourable government initiatives and venture capital funding are surging the market growth over the forecast period. In addition, increasing preventive healthcare practices, efficient management of chronic diseases, and digitalization of the healthcare system are opening new growth prospects for the digital therapeutics market in forecast years. Benefits of digital therapeutics like enhanced drug adherence, the convenience of patients, and its ability to stimulate behavioural changes are spurring the growth of the market. Though, lack of accessibility & awareness about digital therapeutics programs in emerging nations along with the data privacy concerns about patient’s data is among the key factors hampering the growth of the market.
The U.S. FDA in April 2020 rolled out some guidelines to increase the availability of digital health therapeutics gadgets for psychiatric health conditions. Through these guidelines, the FDA aimed to help and support people who were under home quarantine orders or maintaining social distancing, without any in-clinic visit requirements during the COVID-19 pandemic. It can ease down the burdens on the healthcare sector and decrease the risk of exposure to the Covid-19 virus.
The US market dominated the North America Payers Market by Country 2020, thereby, achieving a market value of $901.2 million by 2027. The Canada market is experiencing a CAGR of 24.2% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 23.1% during (2021 - 2027).
Based on End Use, the market is segmented into Patients, Providers, Payers, Employers and Others. Based on Applications, the market is segmented into Diabetes, CNS Disease, Respiratory Diseases, Smoking Cessation, Obesity, CVD and others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Digital Therapeutics Market is Estimated to Reach USD 14.5 Billion by 2027 at a CAGR of 21.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ResMed, Inc. (Propeller Health), Teladoc Health, Inc. (Livongo Health), Noom, Inc., Omada Health, Inc., Welldoc, Inc., Canary Health, Mango Health, Inc. (TrialCard, Incorporated), 2Morrow, Inc., Pear Therapeutics, Inc., and Mindstrong, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End Use
- Patients
- Providers
- Payers
- Employers
- Others
By Application
- Diabetes
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Obesity
- CVD
- others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- ResMed, Inc. (Propeller Health)
- Teladoc Health, Inc. (Livongo Health)
- Noom, Inc.
- Omada Health, Inc.
- Welldoc, Inc.
- Canary Health
- Mango Health, Inc. (TrialCard, Incorporated)
- 2Morrow, Inc.
- Pear Therapeutics, Inc.
- Mindstrong, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Digital Therapeutics Market, by End Use
1.4.2 North America Digital Therapeutics Market, by Application
1.4.3 North America Digital Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Restraints:
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Business Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar – 2021, Mar) Leading Players
Chapter 4. North America Digital Therapeutics Market by End Use
4.1 North America Patients Market by Country
4.2 North America Providers Market by Country
4.3 North America Payers Market by Country
4.4 North America Employers Market by Country
4.5 North America Other End Use Market by Country
Chapter 5. North America Digital Therapeutics Market by Applications
5.1 North America Diabetes Applications Market by Country
5.2 North America CNS Disease Applications Market by Country
5.3 North America Respiratory Diseases Applications Market by Country
5.4 North America Smoking Cessation Applications Market by Country
5.5 North America Obesity Applications Market by Country
5.6 North America CVD Applications Market by Country
5.7 North America Other Applications Market by Country
Chapter 6. North America Digital Therapeutics Market by Country
6.1 US Digital Therapeutics Market
6.1.1 US Digital Therapeutics Market by End Use
6.1.1.1.1 US Digital Therapeutics Market by Applications
6.2 Canada Digital Therapeutics Market
6.2.1 Canada Digital Therapeutics Market by End Use
6.2.2 Canada Digital Therapeutics Market by Applications
6.3 Mexico Digital Therapeutics Market
6.3.1 Mexico Digital Therapeutics Market by End Use
6.3.2 Mexico Digital Therapeutics Market by Applications
6.4 Rest of North America Digital Therapeutics Market
6.4.1 Rest of North America Digital Therapeutics Market by End Use
6.4.2 Rest of North America Digital Therapeutics Market by Applications
Chapter 7. Company Profiles
7.1 ResMed, Inc. (Propeller Health)
7.1.1 Company Overview
7.1.1 Financial Analysis
7.1.2 Segmental and Regional Analysis
7.1.3 Research & Development Expense
7.1.4 Recent strategies and developments:
7.1.4.1 Approvals and Trials:
7.1.4.2 Partnerships, Collaborations, and Agreements:
7.2 Teladoc Health, Inc. (Livongo Health)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Recent strategies and developments:
7.2.3.1 Partnerships, Collaborations, and Agreements:
7.2.3.2 Acquisition and Mergers:
7.3 Noom, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.4 Omada Health, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.4.2.2 Acquisition and Mergers:
7.4.2.3 Product Launches and Product Expansions:
7.5 Welldoc, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Canary Health
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Business Expansions:
7.7 Mango Health, Inc. (TrialCard, Incorporated)
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 2Morrow, Inc.
7.8.1 Company Overview
7.9 Pear Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Acquisition and Mergers:
7.9.2.3 Product Launches and Product Expansions:
7.10. Mindstrong, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 North America Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 2 North America Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Digital Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Digital Therapeutics Market
TABLE 5 Business Expansions– Digital Therapeutics Market
TABLE 6 Acquisition and Mergers– Digital Therapeutics Market
TABLE 7 North America Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 8 North America Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 9 North America Patients Market by Country, 2017 - 2020, USD Million
TABLE 10 North America Patients Market by Country, 2021 - 2027, USD Million
TABLE 11 North America Providers Market by Country, 2017 - 2020, USD Million
TABLE 12 North America Providers Market by Country, 2021 - 2027, USD Million
TABLE 13 North America Payers Market by Country, 2017 - 2020, USD Million
TABLE 14 North America Payers Market by Country, 2021 - 2027, USD Million
TABLE 15 North America Employers Market by Country, 2017 - 2020, USD Million
TABLE 16 North America Employers Market by Country, 2021 - 2027, USD Million
TABLE 17 North America Other End Use Market by Country, 2017 - 2020, USD Million
TABLE 18 North America Other End Use Market by Country, 2021 - 2027, USD Million
TABLE 19 North America Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 20 North America Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 21 North America Diabetes Applications Market by Country, 2017 - 2020, USD Million
TABLE 22 North America Diabetes Applications Market by Country, 2021 - 2027, USD Million
TABLE 23 North America CNS Disease Applications Market by Country, 2017 - 2020, USD Million
TABLE 24 North America CNS Disease Applications Market by Country, 2021 - 2027, USD Million
TABLE 25 North America Respiratory Diseases Applications Market by Country, 2017 - 2020, USD Million
TABLE 26 North America Respiratory Diseases Applications Market by Country, 2021 - 2027, USD Million
TABLE 27 North America Smoking Cessation Applications Market by Country, 2017 - 2020, USD Million
TABLE 28 North America Smoking Cessation Applications Market by Country, 2021 - 2027, USD Million
TABLE 29 North America Obesity Applications Market by Country, 2017 - 2020, USD Million
TABLE 30 North America Obesity Applications Market by Country, 2021 - 2027, USD Million
TABLE 31 North America CVD Applications Market by Country, 2017 - 2020, USD Million
TABLE 32 North America CVD Applications Market by Country, 2021 - 2027, USD Million
TABLE 33 North America Other Applications Market by Country, 2017 - 2020, USD Million
TABLE 34 North America Other Applications Market by Country, 2021 - 2027, USD Million
TABLE 35 North America Digital Therapeutics Market by Country, 2017 - 2020, USD Million
TABLE 36 North America Digital Therapeutics Market by Country, 2021 - 2027, USD Million
TABLE 37 US Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 38 US Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 39 US Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 40 US Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 41 US Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 42 US Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 43 Canada Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 44 Canada Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 45 Canada Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 46 Canada Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 47 Canada Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 48 Canada Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 49 Mexico Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 50 Mexico Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 51 Mexico Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 52 Mexico Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 53 Mexico Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 54 Mexico Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 55 Rest of North America Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 56 Rest of North America Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 57 Rest of North America Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 58 Rest of North America Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 59 Rest of North America Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 60 Rest of North America Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 61 Key Information – ResMed, Inc.
TABLE 62 Key Information – Teladoc Health, Inc.
TABLE 63 key information – Noom, Inc.
TABLE 64 Key Information – Omada Health, Inc.
TABLE 65 key Information – Welldoc, Inc.
TABLE 66 Key Information – Canary Health
TABLE 67 key information – Mango Health, Inc.
TABLE 68 Key Information – 2Morrow, Inc.
TABLE 69 Key Information – Pear Therapeutics, Inc.
TABLE 70 Key Information – Mindstrong, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar – 2021, Mar) Leading Players
FIG 5 Recent strategies and developments: Teladoc Health, Inc.
FIG 6 Recent strategies and developments: Omada Health, Inc.
FIG 7 Recent strategies and developments: Canary Health
FIG 8 Recent strategies and developments: Pear Therapeutics, Inc.